R-2HG downregulates ERalpha to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERalpha/miR16-5p/YAP1 signal pathway.

Gao Y, Ouyang X, Zuo L, Xiao Y, Sun Y, Chang C, Qin X, Yeh S
Mol Ther Oncolytics. 2021 Jul 10;23:65-81. doi: 10.1016/j.omto.2021.06.017. eCollection 2021 Dec 17. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.